维普期刊资源整合服务平台（V6.5）

352篇 您的检索式：作者名="Rustin"

选中清除导出查看参考文献查看引证文献引用追踪共18页首页上一页第1页下一页末页 /18 跳转

	题名	作者	年代	出处	被引量
1	A review of the role of established tumor markers显示文摘	Beastall GH Cook B Rustin GJ	1991	Ann Clin Biochem1991，28，12：	1
2	What surveillance plan should be advised for patients in re- mission after completion of first-line therapy for advanced ovarian canc er显示文摘	Rustin G J	2010	Int J Gynecol Cancer2010，20，2：	1
3	A Phase Ib trial of CA4P (combretastatin A-4 phosphate),carboplatin,and paclitaxel in patients with advanced cancer显示文摘	Rustin G J Shreeves G Nathan P D	2010	Br J Cancer2010，102，9：	1
4	How to follow up patients with epithelial o- varian cancer显示文摘	Miller R E Rustin G J	2010	Curr ()pin Oncol2010，22，49：	1
5	The cost of surveillance following treatment of ovarian cancer显示文摘	Rustin GJ	2013	Gynecol Oncol2013，131，3：	1
6	Human anergic/suppressive CD4 (+)CD25 (+) T ceils: a highly differentiated and apoptosis-prone population 显示文摘	Taams LS Smith J Rustin MH	2001	Eur J Immunol2001，31，4：	1
7	Use of CA-125 in clinical trial evaluation of new therapeutic drugs for ovarian cancer 显示文摘	Rustin GJ Bast RCJr KeUoff GJ	2004	Clin Cancer Res2004，10，11：	1
8	Use of CA-125 in clinical trial evaluation of new therapeutic drugs for ovarian cancer显示文摘	Rustin GJ Bast RC Jr Kelloff CJ		0，，：	1
9	Mutations in the SDHB gene are associated with extra-adrenal and/or malignant phaeochromocytomas显示文摘	Gimenez-Roqueplo A P Favier J Rustin P	2003	Cancer Res2003，63，：	1
10	Combination but not single agent nethotrexate chemotherphy for gestaional trophoblastic turmors increase the incidence of second tumors显示文摘	Rustin GJ Newlands ES Lutz JM	1996	J Clin Oncol1996，14，10：	1
11	Human anergie/suppressive CD4( + )CD25 ( + ) T cells: a highly differentiated and apoptosis- prone population显示文摘	Taams LS Smith J Rustin M H	2001	Eur J Immnnol2001，31，4：	1
12	Comparison of standard and CA-125response criteria in patients with epithelial ovarian cancer treated with platinum or paclitaxel显示文摘	Bridgewater JA Nelstrop AE Rustin GJ	1999	J Clin Oncol1999，17，：	1
13	Role of tumour markers in monitoring epithelial ovarian cancer显示文摘	MEYER T RUSTIN GJ	2000	Br J Cancer2000，82，9：	1
14	Compound heterozygous mutations in the flavoprotein gene of the respiratory chain complex Ⅱ in a patient with Leigh syndrome显示文摘	Parfait B Chretien D Rotig A Marsac C Munnich A Rustin P	2000	Hum Genet2000，106，2：	1
15	Dramatic improvement in mitochondrial Cardiomyopathy following treatment with idebenone显示文摘	Lerman - sagie T Rustin P Lei D	2001	J inherit Metab Dis2001，24，1：	1
16	Use of CA-125 in clinical trial evaluation of new therapeutic drugs for ovarian cancer显示文摘	Rustin GJ Bast RC Jr Kelloff GJ	2004	Clin Cancer Res2004，10，11：	1
17	Use of CA-125 to define progression of ovarian cancer in patients with persistently elevated levels显示文摘	Rustin G J Marples M Nelstrop AE	2001	Clin Oncol2001，19，20：	1
18	The R22X mutation of the SDHD gene in hereditary paraganglioma abolishes the enzymatic activity of complex Ⅱ in the mitochondrial respiratory chain and activates the hypoxia pathway 显示文摘	Gimenez-Roqueplo AP Favier J Rustin P	2001	Am J Hum Genet2001，69，6：	1
19	Expression of purinergic receptors in non melanoma skin cancers and their functional roles in A431 cells显示文摘	Greig A V Linge C Healy V Lim P Clayton E Rustin M H	2003	J Invest Dermatol2003，121，：	1
20	Defining progression of ovarian carcinoma during follow-up according to CA 125:a North Thames Ovary Group Study显示文摘	Rustin GJ Nelstrop AE Tuxen MK	1996	Ann Oncol1996，7，4：	1

返回顶部每页显示：

共18页首页上一页第1页下一页末页 /18 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示